Nanotherapeutics for nose-to-brain drug delivery: an approach to bypass the blood brain barrier
D Lee, T Minko - Pharmaceutics, 2021 - mdpi.com
Treatment of neurodegenerative diseases or other central nervous system (CNS) disorders
has always been a significant challenge. The nature of the blood-brain barrier (BBB) limits …
has always been a significant challenge. The nature of the blood-brain barrier (BBB) limits …
Biological roles of glycans
A Varki - Glycobiology, 2017 - academic.oup.com
Simple and complex carbohydrates (glycans) have long been known to play major
metabolic, structural and physical roles in biological systems. Targeted microbial binding to …
metabolic, structural and physical roles in biological systems. Targeted microbial binding to …
Genome-wide bidirectional CRISPR screens identify mucins as host factors modulating SARS-CoV-2 infection
SB Biering, SA Sarnik, E Wang, JR Zengel, SR Leist… - Nature …, 2022 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes a range of
symptoms in infected individuals, from mild respiratory illness to acute respiratory distress …
symptoms in infected individuals, from mild respiratory illness to acute respiratory distress …
The role of mucus on drug transport and its potential to affect therapeutic outcomes
X Murgia, B Loretz, O Hartwig, M Hittinger… - Advanced drug delivery …, 2018 - Elsevier
A layer of mucus covers the surface of all wet epithelia throughout the human body. Mucus is
a hydrogel mainly composed of water, mucins (glycoproteins), DNA, proteins, lipids, and cell …
a hydrogel mainly composed of water, mucins (glycoproteins), DNA, proteins, lipids, and cell …
Chronic rhinosinusitis pathogenesis
WW Stevens, RJ Lee, RP Schleimer… - Journal of Allergy and …, 2015 - Elsevier
There are a variety of medical conditions associated with chronic sinonasal inflammation,
including chronic rhinosinusitis (CRS) and cystic fibrosis. In particular, CRS can be divided …
including chronic rhinosinusitis (CRS) and cystic fibrosis. In particular, CRS can be divided …
The interaction between respiratory pathogens and mucus
M Zanin, P Baviskar, R Webster, R Webby - Cell host & microbe, 2016 - cell.com
The interaction between respiratory pathogens and their hosts is complex and incompletely
understood. This is particularly true when pathogens encounter the mucus layer covering …
understood. This is particularly true when pathogens encounter the mucus layer covering …
The interplay between the host receptor and influenza virus hemagglutinin and neuraminidase
L Byrd-Leotis, RD Cummings… - International journal of …, 2017 - mdpi.com
The hemagglutinin (HA) and neuraminidase (NA) glycoproteins of influenza A virus are
responsible for the surface interactions of the virion with the host. Entry of the virus is …
responsible for the surface interactions of the virion with the host. Entry of the virus is …
Influenza A penetrates host mucus by cleaving sialic acids with neuraminidase
Abstract Background Influenza A virus (IAV) neuraminidase (NA) cleaves sialic acids (Sias)
from glycans. Inhibiting NA with oseltamivir suppresses both viral infection, and viral release …
from glycans. Inhibiting NA with oseltamivir suppresses both viral infection, and viral release …
A slippery slope: On the origin, role and physiology of mucus
F Taherali, F Varum, AW Basit - Advanced drug delivery reviews, 2018 - Elsevier
The mucosa of the gastrointestinal tract, eyes, nose, lungs, cervix and vagina is lined by
epithelium interspersed with mucus-secreting goblet cells, all of which contribute to their …
epithelium interspersed with mucus-secreting goblet cells, all of which contribute to their …
Single-cell analysis reveals bronchoalveolar epithelial dysfunction in COVID-19 patients
In 2019, a zoonotic coronavirus named severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) was identified as the causative agent of Coronavirus Disease 2019 (COVID …
(SARS-CoV-2) was identified as the causative agent of Coronavirus Disease 2019 (COVID …